These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 21515838)

  • 1. Differential effect of low-dose aspirin for primary prevention of atherosclerotic events in diabetes management: a subanalysis of the JPAD trial.
    Okada S; Morimoto T; Ogawa H; Kanauchi M; Nakayama M; Uemura S; Doi N; Jinnouchi H; Waki M; Soejima H; Sakuma M; Saito Y;
    Diabetes Care; 2011 Jun; 34(6):1277-83. PubMed ID: 21515838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial.
    Ogawa H; Nakayama M; Morimoto T; Uemura S; Kanauchi M; Doi N; Jinnouchi H; Sugiyama S; Saito Y;
    JAMA; 2008 Nov; 300(18):2134-41. PubMed ID: 18997198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose aspirin therapy in patients with type 2 diabetes and reduced glomerular filtration rate: subanalysis from the JPAD trial.
    Saito Y; Morimoto T; Ogawa H; Nakayama M; Uemura S; Doi N; Jinnouchi H; Waki M; Soejima H; Sugiyama S; Okada S; Akai Y;
    Diabetes Care; 2011 Feb; 34(2):280-5. PubMed ID: 21270185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspirin possibly reduces cerebrovascular events in type 2 diabetic patients with higher C-reactive protein level: subanalysis from the JPAD trial.
    Soejima H; Ogawa H; Morimoto T; Nakayama M; Okada S; Sakuma M; Uemura S; Kanauchi M; Doi N; Jinnouchi H; Sugiyama S; Waki M; Saito Y;
    J Cardiol; 2013 Sep; 62(3):165-70. PubMed ID: 23778008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex Difference in Effects of Low-Dose Aspirin on Prevention of Dementia in Patients With Type 2 Diabetes: A Long-term Follow-up Study of a Randomized Clinical Trial.
    Matsumoto C; Ogawa H; Saito Y; Okada S; Soejima H; Sakuma M; Masuda I; Nakayama M; Doi N; Jinnouchi H; Waki M; Morimoto T; ;
    Diabetes Care; 2020 Feb; 43(2):314-320. PubMed ID: 31801787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspirin reduces cerebrovascular events in type 2 diabetic patients with poorly controlled blood pressure. Subanalysis from the JPAD trial.
    Soejima H; Ogawa H; Morimoto T; Nakayama M; Okada S; Uemura S; Kanauchi M; Doi N; Sakuma M; Jinnouchi H; Sugiyama S; Waki M; Saito Y;
    Circ J; 2012; 76(6):1526-32. PubMed ID: 22447019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-Dose Aspirin for Primary Prevention of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus: 10-Year Follow-Up of a Randomized Controlled Trial.
    Saito Y; Okada S; Ogawa H; Soejima H; Sakuma M; Nakayama M; Doi N; Jinnouchi H; Waki M; Masuda I; Morimoto T;
    Circulation; 2017 Feb; 135(7):659-670. PubMed ID: 27881565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One quarter of total myocardial infarctions are silent manifestation in patients with type 2 diabetes mellitus.
    Soejima H; Ogawa H; Morimoto T; Okada S; Sakuma M; Nakayama M; Masuda I; Doi N; Uemura S; Jinnouchi H; Sugiyama S; Waki M; Saito Y;
    J Cardiol; 2019 Jan; 73(1):33-37. PubMed ID: 30487058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose aspirin for primary prevention of cardiovascular events in Japanese patients 60 years or older with atherosclerotic risk factors: a randomized clinical trial.
    Ikeda Y; Shimada K; Teramoto T; Uchiyama S; Yamazaki T; Oikawa S; Sugawara M; Ando K; Murata M; Yokoyama K; Ishizuka N
    JAMA; 2014 Dec; 312(23):2510-20. PubMed ID: 25401325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased complications in noninsulin-dependent diabetic patients treated with insulin versus oral hypoglycemic agents: a population study.
    Savage S; Estacio RO; Jeffers B; Schrier RW
    Proc Assoc Am Physicians; 1997 Mar; 109(2):181-9. PubMed ID: 9069587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Aspirin on Cancer Chemoprevention in Japanese Patients With Type 2 Diabetes: 10-Year Observational Follow-up of a Randomized Controlled Trial.
    Okada S; Morimoto T; Ogawa H; Sakuma M; Matsumoto C; Soejima H; Nakayama M; Doi N; Jinnouchi H; Waki M; Masuda I; Saito Y;
    Diabetes Care; 2018 Aug; 41(8):1757-1764. PubMed ID: 29909377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is Long-Term Low-Dose Aspirin Therapy Associated with Renal Dysfunction in Patients with Type 2 Diabetes? JPAD2 Cohort Study.
    Okada S; Morimoto T; Ogawa H; Sakuma M; Soejima H; Nakayama M; Jinnouchi H; Waki M; Akai Y; Ishii H; Saito Y;
    PLoS One; 2016; 11(1):e0147635. PubMed ID: 26808136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of low-dose aspirin on primary prevention of cardiovascular events in Japanese diabetic patients at high risk.
    Okada S; Morimoto T; Ogawa H; Sakuma M; Soejima H; Nakayama M; Sugiyama S; Jinnouchi H; Waki M; Doi N; Horii M; Kawata H; Somekawa S; Soeda T; Uemura S; Saito Y;
    Circ J; 2013; 77(12):3023-8. PubMed ID: 24042256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Investigation of the effects of low dose aspirin therapy on primary and secondary prevention of cardiovascular disease].
    Soejima H; Ogawa H
    Nihon Rinsho; 2010 May; 68(5):882-6. PubMed ID: 20446587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statins for primary prevention of cardiovascular events and mortality in old and very old adults with and without type 2 diabetes: retrospective cohort study.
    Ramos R; Comas-Cufí M; Martí-Lluch R; Balló E; Ponjoan A; Alves-Cabratosa L; Blanch J; Marrugat J; Elosua R; Grau M; Elosua-Bayes M; García-Ortiz L; Garcia-Gil M
    BMJ; 2018 Sep; 362():k3359. PubMed ID: 30185425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness and safety of basal supported oral therapy with insulin glargine, in Japanese insulin-naive, type 2 diabetes patients, with or without microvascular complications: subanalysis of the observational, non-interventional, 24-week follow-up Add-on Lantus® to Oral Hypoglycemic Agents (ALOHA) study.
    Odawara M; Kadowaki T; Naito Y
    J Diabetes Complications; 2015; 29(1):127-33. PubMed ID: 25449981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of diabetes mellitus and insulin use on survival after acute myocardial infarction in the elderly (the Cooperative Cardiovascular Project).
    Berger AK; Breall JA; Gersh BJ; Johnson AE; Oetgen WJ; Marciniak TA; Schulman KA
    Am J Cardiol; 2001 Feb; 87(3):272-7. PubMed ID: 11165959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteinuria is independently associated with the incidence of primary cardiovascular events in diabetic patients.
    Soejima H; Ogawa H; Morimoto T; Okada S; Matsumoto C; Nakayama M; Masuda I; Jinnouchi H; Waki M; Saito Y;
    J Cardiol; 2020 Apr; 75(4):387-393. PubMed ID: 31564388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucose-lowering with exogenous insulin monotherapy in type 2 diabetes: dose association with all-cause mortality, cardiovascular events and cancer.
    Holden SE; Jenkins-Jones S; Morgan CL; Schernthaner G; Currie CJ
    Diabetes Obes Metab; 2015 Apr; 17(4):350-62. PubMed ID: 25399739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association Between Statins and Cancer Incidence in Diabetes: a Cohort Study of Japanese Patients with Type 2 Diabetes.
    Okada S; Morimoto T; Ogawa H; Soejima H; Matsumoto C; Sakuma M; Nakayama M; Doi N; Jinnouchi H; Waki M; Masuda I; Saito Y
    J Gen Intern Med; 2021 Mar; 36(3):632-639. PubMed ID: 33063203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.